Loss of CHFR in Human Mammary Epithelial Cells Causes Genomic Instability by Disrupting the Mitotic Spindle Assembly Checkpoint  by Privette, Lisa M. et al.
Loss of CHFR in Human
Mammary Epithelial Cells
Causes Genomic Instability by
Disrupting the Mitotic Spindle
Assembly Checkpoint1
Lisa M. Privette*, Jingly Fung Weier†,
Ha Nam Nguyen‡, Xiaochun Yu§
and Elizabeth M. Petty*,§
*Department of Human Genetics, University of Michigan, Ann
Arbor,MI 48109,USA; †DepartmentofObstetrics,Gynecology,
and Reproductive Sciences, University of California, San
Francisco, San Francisco, CA 94143, USA; ‡Institute for Stem
Cell Biology and Regenerative Medicine, Stanford University,
Palo Alto, CA 94304, USA; §Department of Internal Medicine,
University of Michigan, Ann Arbor, MI 48109, USA
Abstract
CHFR is an E3 ubiquitin ligase and an early mitotic checkpoint protein implicated in many cancers and in the main-
tenance of genomic stability. To analyze the role of CHFR in genomic stability, by siRNA, we decreased its expres-
sion in genomically stable MCF10A cells. Lowered CHFR expression quickly led to increased aneuploidy due to
many mitotic defects. First, we confirmed that CHFR interacts with the mitotic kinase Aurora A to regulate its ex-
pression. Furthermore, we found that decreased CHFR led to disorganized multipolar mitotic spindles. This was
supported by the finding that CHFR interacts with α-tubulin and can regulate its ubiquitination in response to no-
codazole and the amount of acetylated α-tubulin, a component of the mitotic spindle. Finally, we found a novel
CHFR interacting protein, the spindle checkpoint protein MAD2. Decreased CHFR expression resulted in the mis-
localization of both MAD2 and BUBR1 during mitosis and impaired MAD2/CDC20 complex formation. Further evi-
dence of a compromised spindle checkpoint was the presence of misaligned metaphase chromosomes, lagging
anaphase chromosomes, and defective cytokinesis in CHFR knockdown cells. Importantly, our results suggest a
novel role for CHFR regulating chromosome segregation where decreased expression, as seen in cancer cells,
contributes to genomic instability by impairing the spindle assembly checkpoint.
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Introduction
Checkpoint with forkhead and RING finger domains (CHFR) is rec-
ognized as a novel mitotic stress checkpoint pathway regulator and
biomarker for chemotherapeutic response of cancer cells to taxanes.
It delays cells in prophase, before the mitotic spindle checkpoint, after
exposure to microtubule poisons (i.e., nocodazole or paclitaxel) [1–7].
Subsequently, CHFR has been implicated in oncogenesis. CHFR ex-
pression is lost or decreased in many types of tumors compared to nor-
mal tissues, sometimes due to promoter hypermethylation [5,7–13].
Importantly, CHFR has strong tumor-suppressive functions in both a
knockout mouse model and in immortalized human mammary epi-
thelial cells (IHMECs) and breast cancer cell lines [3,14]. Prolonged
loss of CHFR expression led to abnormal chromosome complements
(i.e., aneuploidy) in both models.
Aneuploidy is a hallmark of many cancers and may result from
diverse mitotic defects including multipolar spindles secondary to
aberrant cytokinesis or centrosome amplification, sister chromatid
cohesion defects, incorrect centromere attachment, or an impaired mi-
totic spindle assembly checkpoint (“spindle checkpoint”) [15]. The
spindle checkpoint prevents chromosome mis-segregation during cell
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division by delaying anaphase until the kinetochores of all sister chro-
matids are attached to the mitotic spindle microtubules. Spindle
checkpoint gene mutations are rare, especially in breast cancers, but
many cancer cells have an impaired or unregulated spindle checkpoint
[15–17]. Although an accumulating amount of work has been focused
on characterizing the spindle checkpoint, many questions remain. It is
known that MAD2 and BUBR1 are recruited to unattached kineto-
chores early in mitosis. Through a poorly understood mechanism,
MAD2, BUBR1, and BUB3 then sequester CDC20, a cofactor of
the anaphase-promoting complex (APC), to inhibit its ubiquitin ligase
activity and delay anaphase onset. Once all of the kinetochores are at-
tached to the mitotic spindle, the inhibitory complex dissociates and
CDC20 is allowed to bind to the APC, activating its ubiquitin ligase
activity leading to the degradation of securin, separase, and other mi-
totic proteins to permit chromosome segregation (reviewed in Yu
[18]). However, the factors or events that both initiate and stop the
checkpoint-signaling pathway are unclear.
We hypothesized that the transient loss of CHFR would cause
genomic instability by deregulating proteins important for mitotic
spindle formation and function. To test this, we transiently decreased
CHFR expression by siRNA in the genomically stable IHMEC cell
line, MCF10A. Subsequent analysis of these cells revealed that they
were more aneuploid and had increased expression of mitotic pro-
teins including Aurora A, α-tubulin, and acetylated α-tubulin. In ad-
dition, we identified MAD2 as a novel CHFR interacting protein in
which loss of CHFR expression led to impaired MAD2/CDC20
complex formation and the mislocalization of the key spindle check-
point proteins BUBR1 and MAD2. Additional evidence for an im-
paired spindle checkpoint after decreased CHFR expression included
the identification of four mitotic defects: misaligned metaphase chro-
mosomes, lagging anaphase chromosomes, disorganized multipolar
spindles, and defective cytokinesis.
Materials and Methods
Cell Culture
MCF10A and HEK293 cells were obtained from the American
Type Culture Collection (Manassas, VA) and cultured under recom-
mended conditions. For CHFR knockdown, cells were untransfected
(“mock”) or transfected with 2.0 μMof either a nontargeting siControl
siRNA or a set of four siRNAs targeting CHFR using Dharmafect1 ac-
cording to the manufacturer’s instructions and were analyzed 72 hours
later (siGENOME; Dharmacon RNA Technologies, Lafayette, CO).
Cells were transfected with 6.0 μg of a Flag-tagged Aurora A construct
(gift from Xiaochun Yu, University of Michigan) or a Flag-tagged
CHFR using FuGENE 6 (Roche Applied Science, Indianapolis, IN)
and lysates were harvested 24 hours later. Cells were treated with
15 μM of MG132 (Calbiochem, Gibbstown, NJ) for 10 hours and/
or 200 ng/ml nocodazole (Sigma-Aldrich, St. Louis, MO) for 18 hours.
To induce DNA damage, cells were treated with 0.3 μM aphidicolin
for 24 hours.
Spectral Karyotyping and Metaphase Spreads
MCF10A cells were treated with 50 ng/ml colcemid (Invitrogen,
Carlsbad, CA) for 16 hours then collected and resuspended in a
hypotonic solution of 2% KCl and 2% Na3C6H5O7 for 7 minutes
at 37°C. Metaphase spreads were then prepared and stained with
Giemsa as previously described [3]. At least 25 metaphases were
counted in triplicate for each sample.
Spectral karyotyping (SKY) analysis was performed according
to the manufacturer’s protocol (Applied Spectral Imaging, Vista,
CA) and as previously described [19]. Briefly, cells and slides were
prepared as described previously, and unstained slides were aged
in 2× SSC, treated with pepsin (Amresco, Solon, OH; 30 μg/ml in
0.01 N HCl), then rinsed with PBS. Slides were postfixed in 1%
paraformaldehyde in PBS/MgCl2 and dehydrated in an ethanol series
before and after denaturation in a 70% formamide/2× SSC solution.
The denatured SKY probes (vial 1, SKY kit; Applied Spectral Imag-
ing) were hybridized to the slides and incubated at 37°C for 2 days.
After washings, antibodies (from vials 3 and 4, SKY kit) were added
and incubated at 37°C for 1 hour each. The slides were counter-
stained with DAPI in an antifade solution. All images were acquired
using an SD200 SpectraCube spectral imaging system (Applied Spec-
tral Imaging) attached to a microscope (E800; Nikon, Belmont, CA)
consisting of an optical head (a Sagnac interferometer) coupled to a
multiline charge-coupled device camera (Hamamatsu, Bridgewater,
NJ). Spectral Imaging (v. 2.6.1) and Sky View (v. 1.6.2; both from
Applied Spectral Imaging) were used to acquire and analyze the
images, respectively. The average of ten metaphases was used to cre-
ate the consensus karyotype.
Western Blot Analysis
Whole-cell lysates were collected from approximately 80% conflu-
ent cultures. For samples analyzed for ubiquitination of α-tubulin,
2 mM N -ethylmaleimide (NEM; Sigma) was added to the lysis buffer.
Western blots were prepared as previously described [3]. Western
blot membranes were blocked for 1 hour at room temperature and
incubated overnight at 4°C in primary antibody. The following anti-
bodies were used: a mouse CHFR mAb (1:500 dilution; Abnova
Corp., Taipei City, Taiwan), a custom rabbit polyclonal antibody to
the N-terminus of CHFR (1:1000), and a rabbit anti–Aurora A anti-
body (1.0 mg/ml, gift from Xiaochun Yu). A mouse anti–α-tubulin,
mouse anti–acetylated α-tubulin, rabbit anti-Flag (all from Sigma-
Aldrich), rabbit anti–α-tubulin (Cell Signaling Technology, Danvers,
MA), rabbit anti-CDC20 (Novus Biologicals, Littleton, CO), and a
rabbit anti–glutathione-S-transferase (GST; Santa Cruz Biotechnology,
Santa Cruz, CA) were all used at 1:1000 dilutions. Anti-ubiquitin
(1:100; Sigma) was also used to identify ubiquitinated α-tubulin. A
mouse anti-MAD2 (1:500; BD Biosciences, San Jose, CA) and goat
anti-MAD2 (1:250, antibody N19; Santa Cruz Biotechnology) were
also used. An anti–glyceraldehyde-3-phosphate dehyrogenase anti-
body (1:10,000; Abcam, Cambridge, MA) and an HRP-conjugated
β-actin antibody (1:10,000; Sigma-Aldrich) were used for loading con-
trols. Blots were incubated in secondary antibody, anti–mouse:HRP
or anti–rabbit:HRP, diluted in the blocking solution (both from Cell
Signaling Technology). We used the SuperSignal West Pico chemi-
luminescent kit (Pierce Biotechnology, Rockford, IL) and exposed
the blots to a BioMax XAR film (Eastman Kodak, Rochester, NY).
Blots were stripped before reprobing with a different antibody. Where
applicable, blots were analyzed from three experiments to verify ex-
pression changes. Densitometry was performed using an imaging sys-
tem (FluorChem 8900; Alpha Innotech Corp., San Leandro, CA).
Immunoprecipitation
Immunoprecipitations (IPs) were completed according to the
manufacturer’s instructions using the protein G immunoprecipita-
tion kit (Sigma). Briefly, whole-cell lysates were combined with 5
to 10 μl of the specified antibody (mouse IgG1 isotype control from
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BD Biosciences, mouse anti–α-tubulin, mouse anti–Flag M2 anti-
body, or goat anti-MAD2) and diluted in the supplied 1× IP buffer
and incubated for at least 2 hours at 4°C. Then, 50 μl of Protein G
beads were added to the lysate/antibody mix and were incubated
overnight at 4°C. After washes in 1× IP buffer and 0.1× IP buffer,
the immunoprecipitated lysates were boiled in the columns in 40 μl
of 2× Laemmli’s loading buffer then eluted by centrifugation and an-
alyzed by Western blot analysis.
Glutathione-S -Transferase Pull Down
AGST:CHFR fusion construct was created using the pGEX2T vec-
tor (Amersham, Piscataway, NJ) and was expressed in theDH5α strain
of Escherichia coli. Logarithmic E. coli cultures were collected in lysis
buffer (2.5 mM PMSF in 1.0% Triton X-100 with a protease inhibitor
cocktail from Roche), sonicated, and then cleared by centrifugation.
One milligram of E. coli lysates was combined with 50 μl of washed
Glutathione Sepharose 4B beads (Amersham) for 2 hours at 4°C. Then,
1 mg of whole-cell lysates from MCF10A cells was added to the beads
and incubated overnight at 4°C. After washes with NTEN200 buffer
(20 mM Tris–HCl, 1 mM EDTA, 0.5% NP-40, 25 μg/ml PMSF,
and 200 mMNaCl), the bound proteins were eluted with 10 mM glu-
tathione and collected by centrifugation. Isolated proteins were identi-
fied by Western blot analysis.
Yeast Two-Hybrid Screening
Yeast two-hybrid screening was performed following the manu-
facturer’s instructions (Clontech Laboratories, Inc., Mountain View,
CA). Briefly, the full-length cDNA of human CHFR was subcloned
into pGBKT7 to express the fusion peptide with Gal4BD. pGBKT7-
CHFR was introduced into the yeast strain AH109, which was then
transformed with a 293T cell cDNA library cloned into the pACT2
vector. A total of 1 × 107 transformants were plated on SD/−Leu/−Trp/
−His agar medium containing 5 mM 3-aminotriazole, and the colo-
nies that grew in the selective medium were assayed for β-galactosidase
activity. Plasmid DNA was extracted from the positive clones and
was sequenced.
Immunofluorescence
In two-chambered slides, 3 × 105 MCF10A cells were plated in
each chamber, and were then fixed in 4% paraformaldehyde and
blocked in 5% milk, 1.0% BSA in 0.025% TBS–Triton X-100.
Staining was performed using an anti–α-tubulin antibody (1:100;
Sigma), a rabbit anti–Aurora A antibody (1:50; Cell Signaling Tech-
nology), or an anti–Histone H3–phospho-Ser28 antibody (1:100;
Upstate-Millipore, Billerica, MA), all of which were hybridized in
blocking buffer overnight at 4°C. Slides were hybridized with an
anti–mouse:Alexa Fluor 594 or an anti–rabbit:Alexa Fluor 488 sec-
ondary antibody (Invitrogen Molecular Probes, Carlsbad, CA) di-
luted to 1:200 in blocking buffer. Samples were preserved with
ProLong Gold antifade mounting medium with DAPI (Invitrogen
Molecular Probes). For colocalization of CHFR andMAD2, slides were
prepared as described previously using a monoclonal mouse anti–
CHFR antibody (Abnova Corp.) at a 1:50 dilution and a goat anti–
MAD2 antibody (antibody N19; Santa Cruz Biotechnology) at a 1:50
dilution. Anti–mouse:Alexa Fluor 594 and anti–goat:Alexa Fluor
488 secondary antibodies were used at a 1:100 dilution (both from
Invitrogen Molecular Probes).
For BUBR1 and MAD2 localization, cells were fixed in 4% para-
formaldehyde then permeabilized for 5 minutes in 0.5% Triton X-100
dissolved in 1× PBS. Slides were blocked in 5% milk in 0.1% TBS–
Triton X-100 then hybridized with an anti–BUBR1 antibody
(Sigma-Aldrich) or an anti–MAD2 antibody (BD Biosciences) at a
1:200 dilution in blocking buffer overnight at 4°C. Slides were
hybridized with an anti–mouse:Alexa Fluor 594 secondary antibody
(1:500; Invitrogen) diluted in blocking buffer for 1 hour at room
temperature then preserved with ProLong Gold antifade mounting
medium with DAPI (Invitrogen Molecular Probes).
Microscopy
We used a compound Leica DMRB microscope (W. Nuhsbaum,
Inc., McHenry, IL) and either a ×63 or a ×100 objective lens. An ex-
ternal Leica EL6000 light source was used for immunofluorescence
images. Images were recorded using a Retiga 2000R 12-bit digital
camera and QCapture Pro v5.1 software (QImaging, Surrey, Canada).
For the analysis of CHFR andMAD2 colocalization, a confocal micro-
scope (FV-500; Olympus, Center Valley, PA) was used with a ×40
objective lens and FluoView software (Olympus).
Data Analysis
Images were processed for resolution, magnification, and gamma
settings using Adobe Photoshop CS2. We used the analysis of vari-
ance test for statistical significance, and P < .05 was considered sig-
nificant. Error bars depict the SE from triplicate experiments. One
asterisk (*) indicates P ≤ .05 and two asterisks (**) indicate P ≤ .001.
Results
Transient Loss of CHFR Expression Leads to Aneuploidy
We previously reported that the stable loss of CHFR expression
by shRNA in IHMECs led to increased aneuploidy [3]. Further analy-
sis of these cells by SKY revealed two distinct cell populations—
minimally more aneuploid or near tetraploid (Figure 1A compared
to Figure 1, B and C ). The parental karyotype of MCF10A cells,
determined from eight metaphase spreads, was as follows: 48,
XX,1qhph,+del(1)(p?),t(3;9)(p14;p21),+del(7)(q?),i(8)(q10),t(3;5)
(p?;?). The consensus karyotype of five metaphase cells from the
minimally greater aneuploid population of MCF10A cells expressing
CHFR shRNA was as follows: 47∼50,XX,+X,t(1;2)(q?;q?),t(3;9)
(p14;p21),der(6)t(6;19)(p?;?),+del(7)(q?),t(3;5)(p?;?), der(11)t(8;11)
(?;p?), t(15;18)(?;p?),+20. The consensus karyotype from five meta-
phase cells for the near tetraploid population was as follows: 81∼95,
XXXX,−1,t(1;2)(q?;q?),der(2)t(1;2)(q?;q?),−3,t(3;9)(p14;p21)x2,5,
der(6)t(6;19)(p?;?)x2, +del(7)(q?),−9,t(3;5)(p?;?),−10,der(11)t(8;11)
(? ;p? )x2,−13,der(15)t(15;18)(? ;p? )x2,−17,−18x2,+20x2,
−22. MCF10A cells with CHFR shRNA often gained chromo-
somes 20 and X and had four novel chromosomal translocations,
namely, t(1;2), t(6;19), t(8;11), and t(15;18) (Figure 1, B and C ),
suggesting that CHFR may regulate genomic stability through multi-
ple mechanisms.
To determine whether the genomic instability was a byproduct of
prolonged culture after CHFR knockdown, MCF10A cells were tran-
siently transfected with a pool of four siRNAs targeting CHFR
(“MCF10A:CHFR–siRNA cells”) and were analyzed for aneuploidy
and chromosome breakage. CHFR expression was decreased by at least
80% 72 hours after transfection as detected by Western blot analy-
sis (Figure 1D). We observed no chromosome breaks on metaphase
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spreads after treatment with aphidicolin to induce DNA damage (data
not shown). However, 32% of MCF10A:CHFR–siRNA cells showed
increased aneuploidy, typically having 49 to 59 chromosomes, com-
pared to less than 5% of the mock transfected and nontargeting
(“siControl”) negative control counterparts 72 hours after transient
transfection (Figure 1, E and F ; P ≤ .001). This indicated that
CHFR-associated aneuploidy occurs quickly and is not simply a result
of prolonged cell culture conditions. Given this, we wanted to eluci-
date the mechanism(s) by which aneuploidy occurred in IHMECs that
had lost CHFR expression.
CHFR Modulates the Expression of Aurora A
It was previously shown that mouse embryonic fibroblasts (MEFs)
and tissues from CHFR knockout mice overexpressed Aurora A ki-
nase [14]. To assess this and to provide confirmatory evidence in our
human model, we performed Western blot analysis and found that
MCF10A:CHFR–siRNA cells had much greater Aurora A expression
compared to the control cells (Figure 2A). We also found that Flag-
tagged Aurora A could interact with endogenous CHFR in MCF10A
cells by IP (Figure 2B). The physical interaction of these two proteins,
combined with Aurora A overexpression in MCF10A:CHFR–siRNA
cells, substantiates previously published observations that Aurora A is a
target for CHFR-mediated ubiquitination for degradation [14].
Early in mitosis, Aurora A localizes to centrosomes where it me-
diates their maturation and separation and spindle formation [20].
We found that Aurora A properly localized to the centrosomes during
metaphase, as evidenced by the two distinct foci that colocalized to the
spindle poles, and less than 1.5% of control cells had greater than two
Aurora A foci (Figure 2, C , subpanels b, d, f, and h, and D). However,
although Aurora A was properly localized, in 16% of MCF10A:
CHFR–siRNA cells, more than two Aurora A foci were detected, in-
dicating increased Aurora A expression and suggesting centrosome
amplification (Figure 2, C subpanels j and l, and D; P < .05).
CHFR Regulates α-Tubulin Expression
In MCF10A:CHFR–siRNA cells, the mitotic spindle was often
more condensed with poor polar microtubule formation (Figure 2C ,
subpanels i and l ). Because CHFR is best known for its role in delay-
ing mitotic entry due to stress on the microtubules, we hypothesized
that CHFR may interact with, and possibly regulate, tubulin pro-
teins. We performed a GST pull down using a purified GST:CHFR
fusion protein and lysates from MCF10A cells. We found that
CHFR interacts with α-tubulin when the MCF10A cells were previ-
ously treated with nocodazole (Figure 3A). In addition, this was con-
firmed by coimmunoprecipitation experiments with a Flag-tagged
CHFR construct expressed in HEK293 cells in which IP of both
Figure 1. Decreased CHFR expression causes increased aneuploidy. (A) SKY analysis of parental MCF10A cells shows the characteristic
karyotype of this genomically stable hyperdiploid cell line. (B and C) SKY analysis of MCF10A cells stably expressing shRNA against CHFR
are either minimally aneuploid (B) or nearly tetraploid (C) and show novel chromosome translocations. (D) Western blot analysis shows
>80% decrease in CHFR expression in MCF10A cells transiently transfected with siRNA against CHFR (“CHFR siRNA”) compared to un-
transfected (“mock”) and nontargeting siRNA (“siControl”) transfected cells after 72 hours. (E) Metaphase spreads show that MCF10A:
CHFR–siRNA cells (right panel) are more aneuploid. Scale bar, 25 μm. (F) Frequency of increased aneuploidy in transiently transfected
MCF10A cells.
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Flag-CHFR and α-tubulin were able to coimmunoprecipitate the other
protein. However, the interaction was not dependent on nocodazole
treatment using this method (Figure 3B).
To determine whether CHFR can ubiquitinate α-tubulin, we treated
MCF10A cells that had been transfected with control or CHFR siRNAs
with the proteasome inhibitor MG132 with or without concomitant
treatment with nocodazole. After IP for α-tubulin and immunoblot
analysis for ubiquitin, we found that CHFR is able to ubiquitinate
α-tubulin during nocodazole exposure, as evidenced by the loss of
ubiquitin signal in MCF10A:CHFR–siRNA cells (Figure 3C , lane
3 vs lane 6 ). Western blot analysis confirmed that CHFR can regu-
late α-tubulin because there was a reproducible increase in α-tubulin
protein levels in MCF10A:CHFR–siRNA cells (Figure 3, D and E ;
P < .05). The amount of acetylated α-tubulin, a key component of
the mitotic spindle, in MCF10A:CHFR–siRNA cells was consistently
double that of controls (Figure 4, C and D; P < .05).
CHFR Interacts with MAD2 and Regulates the Mitotic
Spindle Checkpoint
Because CHFR is an E3 ubiquitin ligase, it likely interacts with
several proteins to regulate mitotic events. In an effort to identify
novel CHFR interacting partners, we performed a yeast two-hybrid
screen using a full-length human CHFR cDNA as bait. A 293T cell
cDNA library was screened by using the Gal4-based yeast two-hybrid
system. By screening 1 × 107 clones, we found nine positive clones.
Among nine positive clones, three clones encoded the E2 ubiquitin-
conjugating enzyme UBE2N, further confirming the effectiveness of
our yeast two-hybrid screening. We also identified Epsin, SKAP55,
an uncharacterized protein encoded by cDNA FLJ14707, cone-rod
homeobox protein (CRX), and electron transfer flavoprotein alpha
subunit (ETFA) as additional CHFR interacting proteins. One clone
encoded the full length of MAD2, a spindle checkpoint protein that
ensures proper chromosome segregation.
To confirm an interaction between CHFR and MAD2 in vivo, we
performed immunofluorescence with confocal microscopy to visualize
endogenous CHFR and MAD2 proteins. These two proteins colocal-
ized in the cytoplasm of interphase cells and strongly colocalized in
mitotic cells, particularly during metaphase and anaphase (Figure 4A,
subpanels c and d). Of note, both proteins exhibited brighter staining in
mitotic cells, indicating that their expression is higher during mitosis
when compared to interphase cells. We also performed coimmunopre-
cipitation experiments by expressing a Flag-tagged full-length CHFR
cDNA in HEK293 cells. By immunoprecipitating Flag:CHFR and by
immunoblot analysis for MAD2, we found additional evidence sup-
porting an interaction between CHFR and MAD2 (Figure 4B).
In addition, we studied the localization of two critical spindle check-
point proteins, BUBR1 and MAD2, during mitosis. Normally, both
proteins have a punctate staining pattern early in mitosis, reflecting
their localization to unattached kinetochores. When MAD2 is re-
cruited to the kinetochore, it undergoes a conformation change that
increases its affinity for CDC20 binding [18]. Staining becomes dif-
fuse later in mitosis after all chromosomes are attached to the mitotic
spindle and the two proteins dissociate from CDC20 and the kineto-
chores, thereby allowing CDC20 to activate APC and allow the initi-
ation of anaphase. Normal BUBR1 and MAD2 staining patterns were
observed in negative control cells in metaphase (Figure 4,C andD). In
Figure 2. CHFR interacts with Aurora A and regulates its protein expression. (A) MCF10A:CHFR–siRNA cells overexpress Aurora A, as
shown by Western blot analysis, compared to control cells. (B) Flag:Aurora A interacts with endogenous CHFR by coimmunoprecipita-
tion. Lysates from MCF10A cells transiently transfected with Flag-tagged Aurora A were subjected to IP with an anti-Flag (M2) antibody
then probed for CHFR or Flag by Western blot analysis using rabbit antibodies. “Input” on the left indicates 10% of the lysates used for
the IP reaction. (C) Immunofluorescence for Aurora A (green) indicates that MCF10A:CHFR–siRNA cells (bottom row) have greater than
two Aurora A foci when compared to two foci in negative control cells during metaphase. Cells were stained with DAPI (blue) for DNA
and for α-tubulin (red) to see the spindle. Note the compacted, disorganized mitotic spindle (red) in CHFR–siRNA cells (subpanel l com-
pared to subpanels d and h). (D) Quantification of the data in (C), showing that nearly 16% of MCF10A cells transfected with CHFR
siRNA had greater than two Aurora A foci whereas less than 1.5% of control cells had greater than two foci.
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contrast, MCF10A:CHFR–siRNA cells demonstrated diffuse BUBR1
and MAD2 staining early in metaphase, indicating that both proteins
were not properly localizing to the kinetochores of unattached chro-
mosomes (Figure 4, C and D, right panels).
The spindle checkpoint can be activated by treating cells with
microtubule-targeting poisons like nocodazole. As mentioned previ-
ously, MAD2 recruited to the kinetochores binds to CDC20 to seques-
ter it from the APC and prevent anaphase onset, especially in response
to microtubule-targeting drugs. Due to the mislocalization of MAD2
in MCF10A:CHFR–siRNA cells described previously, we hypothesized
that MAD2/CDC20 complex formation would be compromised in
CHFR knockdown cells. To test this, we coimmunoprecipitated
CDC20 with MAD2 in nocodazole-treated control and MCF10A:
CHFR–siRNA cells. We discovered that significantly lowered CHFR ex-
pression impaired MAD2/CDC20 complex formation in nocodazole-
treated MCF10A cells, as evidenced by the decrease in CDC20 signal
in MCF10A:CHFR–siRNA cells compared to controls despite equal
amounts of MAD2 being immunoprecipitated (Figure 4E).
Given the evidence that CHFR may participate in the spindle
checkpoint by interacting with MAD2 and regulating its function
and localization, we performed immunofluorescence to visualize chro-
mosomes during mitosis to determine whether the spindle checkpoint
was functioning to properly segregate sister chromatids. Nearly 25% of
MCF10A:CHFR–siRNA cells had metaphase chromosomes not
properly located to the metaphase plate, which was much higher than
the approximately 3% frequency observed in the control cells (Fig-
ure 5, A and B). Lagging chromosomes and chromosome bridges were
also observed during anaphase in MCF10A:CHFR–siRNA cells (Fig-
ure 5C ). This suggested that the spindle checkpoint was disrupted in
cells with decreased CHFR expression.
One potential outcome of chromosome nondisjunction is im-
paired cytokinesis, resulting in binucleated cells and potential tetra-
ploidy [21]. As noted previously, nearly 13% of cells with stably
decreased CHFR by shRNA were binucleated and tetraploid (Fig-
ure 1A and data not shown). In fact, 6% of transiently transfected
MCF10A:CHFR–siRNA cells were also binucleated when analyzed
Figure 3. CHFR ubiquitinates α-tubulin and regulates α-tubulin protein expression. (A) A GST pull down using a GST:CHFR fusion protein
shows that CHFR can interact with α-tubulin from MCF10A whole-cell lysates as shown by Western blot analysis. The “input” is 10% of
the MCF10A whole-cell lysates used for the GST pull down. MCF10A cells were either untreated (−Noc) or treated with nocodazole
(+Noc) before lysate collection. (B) CHFR interacts with α-tubulin by coimmunoprecipitation. A Flag:CHFR construct was transfected
into HEK293 cells and the lysates were used for IP with either anti-Flag or anti–α-tubulin mouse antibodies then Western blotted (WB)
with either anti-Flag or anti–α-tubulin rabbit antibodies. Cells were either untreated or treated with nocodazole. The “input” indicates
5% of the lysates used for the IP reaction. (C) CHFR ubiquitinates α-tubulin in nocodazole-treated cells. MCF10A cells were cultured
in MG132 and either untreated or simultaneously treated with nocodazole. Western blot analysis of immunoprecipitated α-tubulin
for ubiquitin shows that the amount of ubiquitinated α-tubulin is dramatically decreased in MCF10A:CHFR–siRNA cells treated with
nocodazole. The “input” indicates 10% of the lysates used for the IP reaction. (D) Western blot analysis reveals that MCF10A:CHFR–
siRNA cells have a modest increase in unmodified and acetylated α-tubulin protein levels compared to control cells. (E) A graphic rep-
resentation of the data presented in (D) from triplicate experiments. There was a reproducible 1.6-fold increase in unmodified α-tubulin
and a twofold increase in acetylated α-tubulin in MCF10A:CHFR–siRNA cells.
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by immunofluorescence, suggesting possible tetraploidy, compared to
only approximately 1% of negative control cells (Figure 5, D and E ;
P < .05). This was confirmed by the occasional tetraploid MCF10A:
CHFR–siRNAmetaphase spread when cells were assessed for aneuploidy.
Discussion
The work presented here indicates that CHFR is extremely impor-
tant for the maintenance of genomic stability in mammary epithelial
cells. Our results support and help explain the previously published
findings of aneuploidy in MEFs from Chfr null mice and IHMEC
lines [3,14]. The observed chromosome rearrangements that we noted
by spectral karyotyping likely resulted from prolonged culture, and
the disruption of DNA damage response genes secondary to the
aneuploidy, which we have shown can develop within a few days after
decreased CHFR expression. To the contrary, the presence of addi-
tional chromosomes with a numeric change in chromosome number,
or aneuploidy, in cells treated with siRNA against CHFR provides
powerful evidence that CHFR is required for genomic stability
through proper chromosome segregation during mitosis. Further-
more, the lack of chromosome breaks on the metaphase spreads from
MCF10A cells transiently transfected with siRNA to decrease CHFR
mRNA and protein suggested that CHFR might not participate di-
rectly in the DNA damage response induced by aphidicolin. This
conclusion is supported by previous studies in which CHFR expres-
sion did not alter the DNA damage response after treatment with
other genotoxic reagents [1,22].
We were able to confirm the previously published finding that
Chfr can regulate Aurora A expression in the mouse also holds true
in humans [14]. Aurora A is amplified and overexpressed in many
cancers, including breast cancer, and overexpression in cultured hu-
man cells leads to transformation [20,23]. In addition, a transgenic
mouse overexpressing Aurora A in the mammary epithelium leads to
Figure 4. CHFR interacts with MAD2 and decreased CHFR expression causes the mislocalization of spindle checkpoint proteins MAD2
and BUBR1 and alters MAD2/CDC20 complex formation. (A) Immunofluorescence indicates that endogenous CHFR (red) and MAD2
(green) colocalize (yellow) in the cytoplasm of interphaseMCF10A cells and strongly colocalize in mitotic cells. DNAwas stained blue with
DAPI. Scale bar, 50 μm. Subpanels a to e are magnified images from the merged image indicating cells in interphase (a), prophase (b),
metaphase (c), anaphase (d), and telophase/cytokinesis (e). (B) Endogenous MAD2 interacts with CHFR. HEK293 cells were transfected
with a Flag-tagged CHFR construct, with orwithout nocodazole treatment. Immunoprecipitationwith an anti–Flag antibodywas performed
to isolate CHFR and subsequently analyzed by Western blot analysis (WB) for the Flag:CHFR fusion protein and endogenous MAD2. “In-
put” indicates 5% of the lysates used for the IP reaction. (C and D) Immunofluorescence to visualize BUBR1 and MAD2 reveals that cells
with CHFR siRNA (right panels) have diffuse BUBRI and MAD2 staining patterns (red, D and E, respectively) indicating mislocalization.
Control cells have the characteristic punctate staining patterns for BUBR1 and MAD2. DNA was stained blue with DAPI. Scale bar,
5 μm. (E) Decreased CHFR expression by siRNA impairs MAD2/CDC20 complex formation. Whole-cell lysates from control and CHFR
siRNA-transfected MCF10A cells treated with nocodazole were subjected to IP with an anti-MAD2 antibody. Samples were subsequently
analyzed by Western blot (WB) for both CDC20 and MAD2. “Input” lysates, representing 15% of the samples used for IP, were probed by
Western blot analysis for CDC20 and MAD2, for CHFR to show efficient knockdown of expression, and for β-actin as a loading control.
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tumor formation and genomic instability [24]. The chromosome mis-
segregation phenotypes in MCF10A:CHFR–siRNA cells were also
highly reminiscent of MEFs that overexpress Aurora A [25]. CHFR
was recently characterized as a tumor suppressor and, as shown here,
many of its genomic instability phenotypes resemble Aurora A over-
expression; therefore, we propose that one major mechanism by which
CHFR inhibits oncogenesis may be through its negative regulation
of Aurora A [3,14]. Novel drugs currently are being generated that
target the Aurora kinases [26]. Because decreased CHFR expression
has been linked to sensitivity to microtubule-targeting drugs, future
studies may find a synergistic effect when taxanes and Aurora kinase
inhibitors are both used for treatment.
These findings also indicate that CHFR may play a role in regulat-
ing α-tubulin turnover or stability, especially after microtubule stress.
This is the first clue as to how the “CHFR checkpoint” responds to
microtubule poisons, although an unidentified signaling cascade is
also likely to be involved in this checkpoint. The ubiquitination and
possible degradation ofα-tubulin may be necessary to remove thoseα/
β–tubulin dimers that are targeted by microtubule poisons. In un-
stressed cells, CHFR may also be required for proper spindle forma-
tion because it seems to regulate the amount of acetylated α-tubulin,
an important component of the mitotic spindle. Aurora A kinase is
also required for proper spindle formation, supposedly through its pos-
itive regulation of a protein called HURP [27]. HURP is required for
both chromosome congression and alignment and for the polymeriza-
tion and stabilization of microtubules during mitotic spindle forma-
tion. Therefore, the capacity of CHFR to control spindle formation
may be through its upstream regulation of Aurora A, although it
may also be due to CHFR’s capability to ubiquitinate α-tubulin and
control the amount of acetylatedα-tubulin that is available for use dur-
ing spindle assembly.
One of the characteristics of stabilized microtubules is the acety-
lation of α-tubulin on residue lysine 40. Acetylated α-tubulin is as-
sociated with decreased microtubule turnover and is localized to the
mitotic spindle, centrosomes, and the mitotic midbody [28,29]. An
increase in acetylated α-tubulin, such as that observed here, would
likely result in overstabilized microtubules that would hinder mi-
totic spindle movement or would prevent its proper formation. This
may help to explain why CHFR-negative cells are more sensitive to
taxanes. The cellular strain of the excess of overstabilized acetylated
microtubules, combined with stress induced by microtubule poisons,
may enable the cell to surpass a threshold of tolerable stress that
would result in apoptosis. This hypothesis is supported by reports
of a synergistic effect on both apoptotic response and microtubule
stabilization, as indicated by acetylated α-tubulin, when endometrial
cancer cells are treated with both the histone deacetylase inhibitor
(HDI) trichostatin A and paclitaxel [30]. Interestingly, some of the tar-
gets of HDIs are also tubulin deacetylase proteins, such as HDAC6
Figure 5. Decreased CHFR expression impairs the mitotic spindle checkpoint. (A) Chromosomes did not properly migrate to the meta-
phase plate in MCF10A:CHFR–siRNA cells (arrow, right panel). Immunofluorescence (IF) detected phosphorylated Histone H3–Ser28
(green) to identify metaphase chromosomes. (B) A graph of the data shown in (A); 24% of cells with CHFR siRNA have chromosomes
improperly located during metaphase. (C) MCF10A:CHFR–siRNA cells have lagging chromosomes and chromosome bridges during
anaphase (arrow, right panel). DNA was stained blue with DAPI. Scale bar, 5 μm. (D) Immunofluorescence to detect cytoskeletal α-
tubulin (red) during interphase shows that MCF10A:CHFR–siRNA cells become binucleated (subpanels c and d; arrow) compared to
the negative control cells (subpanels a and b). Scale bar, 50 μm. (E) Quantification of the data shown in (D), in which 6% of MCF10A cells
transfected with CHFR siRNA are binucleated compared to less than 2% of control cells. One asterisk (*) indicates that P< .05, whereas
two asterisks (**) indicates that P < .001.
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and SIRT2 [31,32]. Recent studies also show that treating cells with
HDIs down-regulates Aurora A expression [33]. Future clinical studies
may find that the synergistic effect between HDIs and taxanes may be
different in CHFR-positive versus CHFR-negative cancer cells.
The finding that CHFR knockdown results in increased amounts
of acetylated α-tubulin is particularly interesting because another
protein that has been found to initiate a “CHFR checkpoint-like”
response to microtubule poisons is SIRT2, a tubulin and histone de-
acetylase [34]. SIRT2 overexpression is a phenocopy of CHFR over-
expression in regards to the regulation of mitotic entry and response
to mitotic stress. Therefore, hypothetically, decreased SIRT2 expres-
sion should resemble decreased CHFR expression in both the re-
sponse to mitotic stress and the amount of acetylated α-tubulin in
the cell. Future studies should determine whether the increase in
acetylated α-tubulin after decreased CHFR expression is due to
SIRT2 or through the activation of Aurora A–regulated HURP.
We report here the identification of a novel CHFR interacting
protein, MAD2. Although we found no evidence that MAD2 is a
ubiquitination target of CHFR (data not shown), we noticed that
when CHFR expression was drastically reduced and the cells were
treated with nocodazole to induce the checkpoint response, there
was a slight decrease in MAD2 protein levels (Figure 4E ). This sug-
gests that another ubiquitin ligase is possibly degrading MAD2 pre-
maturely, or to a greater degree, in the absence of CHFR. Because
decreased CHFR expression impairs MAD2/CDC20 complex for-
mation, we hypothesize that, in this scenario, CDC20 is prematurely
activating the APC complex to initiate anaphase and ubiquitinate tar-
get mitotic proteins, such as MAD2. Alternately, MAD2 expression
itself may be down-regulated in nocodazole-treated cells with de-
creased CHFR expression. Further studies are warranted to clarify
the mechanism(s) of impaired MAD2 function and expression in
cells with decreased CHFR expression.
With an impaired spindle checkpoint, cells with decreased CHFR
expression could enter anaphase without all of their chromosomes
localized to the metaphase plate and the sister chromatids attached
to the mitotic spindle, leading to the appearance of lagging chromo-
somes and unequal chromosome segregation among the two daughter
cells, such as that reported here. One potential outcome of improper
chromosome segregation is the abortion of cytokinesis, resulting in bi-
nucleated cells and tetraploidy, which was also observed in this work
[21]. Of interest, our work strongly agrees with previous findings that
the yeast orthologs of CHFR, DMA1 and DMA2, also function in
regulating the spindle checkpoint and cytokinesis [35,36].
A recent report indicated that one isoform of CHFR (Accession No.
AF_170724; the same isoformwas used in this article) contains a KEN
boxmotif, which targets proteins to the CDH1–APC complex for deg-
radation. This further supports a role for CHFR in regulatingmitosis and
the spindle checkpoint [37]. Although we found that a KEN box dele-
tion mutant of CHFR did not impair CHFR/MAD2 coimmunoprecip-
itation (data not shown), further studies are warranted to determine
whether the KEN box in CHFR is required for spindle checkpoint func-
tion and/or degradation by the CDH1–APC complex.
We also discovered that CHFR overexpression is toxic to many
breast cell lines independent of the method of transfection or retro-
viral transduction (both transient and stable; data not shown), which
is why HEK293 cells were used to express the Flag-tagged CHFR
construct used in coimmunoprecipitation experiments. This suggests
that CHFR expression must be tightly regulated—too much is toxic
whereas too little causes genomic instability and tumorigenesis. This
is reminiscent of other mitotic checkpoint proteins, such as MAD2,
in that both too little and too much of the protein are deleterious
[38]. Recently, this finding was also reported in HCT116 and
RKO colon cancer cell lines [39]. Determining the mechanism(s)
causing CHFR overexpression toxicity likely will answer many of
the questions that remain about the function of CHFR.
These findings have led us to propose a model for how CHFR may
regulate genomic instability and/or tumorigenesis (Figure 6). We
suggest that decreased or lost CHFR expression causes overexpres-
sion of Aurora A and both unmodified and acetylated α-tubulin,
and the mislocalization of MAD2. Aurora A overexpression could
lead to centrosome amplification, an impaired spindle checkpoint,
and possibly defective mitotic spindle formation, leading to aneu-
ploidy and impaired cytokinesis. The mislocalization of MAD2 also
causes an impaired spindle checkpoint response. The increase in
acetylated α-tubulin could cause stress on the mitotic spindle. Both
pathways would lead to genomic instability, contributing to tumori-
genesis. As indicated by the generality of this model, much research
remains to elucidate the role of CHFR in regulating mitosis and ge-
nomic instability.
Many reports have indicated that CHFR plays an important role
in carcinogenesis and has tumor-suppressive qualities. An abundance
of evidence indicates that CHFR mRNA expression is decreased in
many cancer types, often due to promoter methylation (reviewed
in Privette and Petty [40]). In addition, a knockout mouse model
and cell culture models of lost or decreased expression, respectively,
indicate that CHFR has tumor-suppressive qualities [3,14]. Addi-
tional evidence for CHFR’s role in tumorigenesis is that it is impor-
tant for cell cycle regulation, chemotherapeutic response to taxanes,
and cellular proliferation [3,6,39] (reviewed in Privette and Petty
Figure 6. A proposedmodel of how CHFR regulates genomic insta-
bility. Decreased or lost CHFRexpression causesAurora A,α-tubulin,
and acetylated α-tubulin overexpression andMAD2mislocalization.
The increase in acetylated α-tubulin occurs by an unknown mecha-
nism, possibly through HURP or SIRT2 and may stress the mitotic
spindle. Aurora A overexpression causes centrosome amplifica-
tion. Both Aurora A overexpression and MAD2 mislocalization re-
sult in an impaired spindle checkpoint, contributing to aneuploidy
and/or failed cytokinesis. Both processes lead to mitotic defects
causing genomic instability and possibly tumorigenesis.
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[40]). Here, we present novel evidence for an additional tumor-
suppressive function of CHFR—maintaining genomic stability by
regulating the mitotic spindle assembly checkpoint. Cancer often de-
velops in concert with the loss of cell cycle regulation and genomic
instability; CHFR may function in both processes.
Acknowledgments
The authors thank Esther Peterson for helpful suggestions and Sally
Camper for sharing her Leica DMRB microscope.
References
[1] Chaturvedi P, Sudakin V, Bobiak ML, Fisher PW, Mattern MR, Jablonski SA,
Hurle MR, Zhu Y, Yen TJ, and Zhou BB (2002). Chfr regulates a mitotic stress
pathway through its RING-finger domain with ubiquitin ligase activity. Cancer
Res 62, 1797–1801.
[2] Ogi K, Toyota M, Mita H, Satoh A, Kashima L, Sasaki Y, Suzuki H, Akino K,
Nishikawa N, Noguchi M, et al. (2005). Small interfering RNA-induced CHFR
silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors.
Cancer Biol Ther 4, 773–780.
[3] Privette LM, Gonzalez ME, Ding L, Kleer CG, and Petty EM (2007). Altered
expression of the early mitotic checkpoint protein, CHFR, in breast cancers: im-
plications for tumor suppression. Cancer Res 67, 6064–6074.
[4] Sakai M, Hibi K, Kanazumi N, Nomoto S, Inoue S, Takeda S, and Nakao A
(2005). Aberrant methylation of the CHFR gene in advanced hepatocellular car-
cinoma. Hepatogastroenterology 52, 1854–1857.
[5] Satoh A, Toyota M, Itoh F, Sasaki Y, Suzuki H, Ogi K, Kikuchi T, Mita H,
Yamashita T, Kojima T, et al. (2003). Epigenetic inactivation of CHFR and sen-
sitivity to microtubule inhibitors in gastric cancer. Cancer Res 63, 8606–8613.
[6] Scolnick DM and Halazonetis TD (2000). Chfr defines a mitotic stress check-
point that delays entry into metaphase. Nature 406, 430–435.
[7] Yanokura M, Banno K, Kawaguchi M, Hirao N, Hirasawa A, Susumu N,
Tsukazaki K, and Aoki D (2007). Relationship of aberrant DNA hypermeth-
ylation of CHFR with sensitivity to taxanes in endometrial cancer. Oncol Rep
17, 41–48.
[8] Corn PG, Summers MK, Fogt F, Virmani AK, Gazdar AF, Halazonetis TD, and
El-Deiry WS (2003). Frequent hypermethylation of the 5′ CpG island of the
mitotic stress checkpoint gene Chfr in colorectal and non–small cell lung cancer.
Carcinogenesis 24, 47–51.
[9] Erson AE and Petty EM (2004). CHFR-associated early G2/M checkpoint de-
fects in breast cancer cells. Mol Carcinog 39, 26–33.
[10] Honda T, Tamura G, Waki T, Kawata S, Nishizuka S, and Motoyama T (2004).
Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic
gastric epithelia. Br J Cancer 90, 2013–2016.
[11] Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y,
and Takahashi T (2002). Aberrant hypermethylation of the CHFR prophase
checkpoint gene in human lung cancers. Oncogene 21, 2328–2333.
[12] Shibata Y, Haruki N, Kuwabara Y, Ishiguro H, Shinoda N, Sato A, Kimura M,
Koyama H, Toyama T, Nishiwaki T, et al. (2002). Chfr expression is downreg-
ulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis 23,
1695–1699.
[13] Toyota M, Sasaki Y, Satoh A, Ogi K, Kikuchi T, Suzuki H, Mita H, Tanaka N,
Itoh F, Issa JP, et al. (2003). Epigenetic inactivation of CHFR in human tumors.
Proc Natl Acad Sci USA 100, 7818–7823.
[14] Yu X, Minter-Dykhouse K, Malureanu L, Zhao WM, Zhang D, Merkle CJ,
Ward IM, Saya H, Fang G, van Deursen J, et al. (2005). Chfr is required for
tumor suppression and Aurora A regulation. Nat Genet 37, 401–406.
[15] Kops GJ, Weaver BA, and Cleveland DW (2005). On the road to cancer: an-
euploidy and the mitotic checkpoint. Nat Rev Cancer 5, 773–785.
[16] Myrie KA, Percy MJ, Azim JN, Neeley CK, and Petty EM (2000). Mutation
and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer
cell lines. Cancer Lett 152, 193–199.
[17] Percy MJ, Myrie KA, Neeley CK, Azim JN, Ethier SP, and Petty EM (2000).
Expression and mutational analyses of the human MAD2L1 gene in breast can-
cer cells. Genes Chromosomes Cancer 29, 356–362.
[18] Yu H (2002). Regulation of APC-Cdc20 by the spindle checkpoint. Curr Opin
Cell Biol 14, 706–714.
[19] McGhee EM, Cotter PD, Weier JF, Berline JW, Turner MA, Gormley M, and
Palefsky JM (2006). Molecular cytogenetic characterization of human papillo-
mavirus 16–transformed foreskin keratinocyte cell line 16-MT. Cancer Genet
Cytogenet 168, 36–43.
[20] Marumoto T, Zhang D, and Saya H (2005). Aurora-A—a guardian of poles.
Nat Rev Cancer 5, 42–50.
[21] Shi Q and King RW (2005). Chromosome nondisjunction yields tetraploid
rather than aneuploid cells in human cell lines. Nature 437, 1038–1042.
[22] Summers MK, Bothos J, and Halazonetis TD (2005). The CHFR mitotic
checkpoint protein delays cell cycle progression by excluding Cyclin B1 from
the nucleus. Oncogene 24, 2589–2598.
[23] Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, and Sen
S (1998). Tumour amplified kinase STK15/BTAK induces centrosome ampli-
fication, aneuploidy and transformation. Nat Genet 20, 189–193.
[24] WangX,ZhouYX,QiaoW,Tominaga Y,OuchiM,Ouchi T, andDengCX (2006).
Overexpression of aurora kinase A in mouse mammary epithelium induces genetic
instability preceding mammary tumor formation. Oncogene 25, 7148–7158.
[25] Anand S, Penrhyn-Lowe S, and Venkitaraman AR (2003). AURORA-A ampli-
fication overrides the mitotic spindle assembly checkpoint, inducing resistance
to Taxol. Cancer Cell 3, 51–62.
[26] Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W,
Galvin KM, Hoar KM, Huck JJ, LeRoy PJ, et al. (2007). Antitumor activity
of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc
Natl Acad Sci USA 104, 4106–4111.
[27] Yu CT, Hsu JM, Lee YC, Tsou AP, Chou CK, and Huang CY (2005). Phos-
phorylation and stabilization of HURP by Aurora-A: implication of HURP as a
transforming target of Aurora-A. Mol Cell Biol 25, 5789–5800.
[28] Piperno G, LeDizet M, and Chang XJ (1987). Microtubules containing acety-
lated alpha-tubulin in mammalian cells in culture. J Cell Biol 104, 289–302.
[29] Webster DR and Borisy GG (1989). Microtubules are acetylated in domains
that turn over slowly. J Cell Sci 92 (Pt 1), 57–65.
[30] Dowdy SC, Jiang S, Zhou XC, Hou X, Jin F, Podratz KC, and Jiang SW (2006).
Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apop-
tosis and microtubule stabilization in papillary serous endometrial cancer cells.
Mol Cancer Ther 5, 2767–2776.
[31] North BJ, Marshall BL, Borra MT, Denu JM, and Verdin E (2003). The human
Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11,
437–444.
[32] Zhang Y, Li N, Caron C, Matthias G, Hess D, Khochbin S, and Matthias P
(2003). HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo.
EMBO J 22, 1168–1179.
[33] Park JH, Jong HS, Kim SG, Jung Y, Lee KW, Lee JH, Kim DK, Bang YJ, and
Kim TY (2008). Inhibitors of histone deacetylases induce tumor-selective cyto-
toxicity through modulating Aurora-A kinase. J Mol Med 86, 117–128.
[34] Inoue T, Hiratsuka M, Osaki M, Yamada H, Kishimoto I, Yamaguchi S,
Nakano S, Katoh M, Ito H, and Oshimura M (2007). SIRT2, a tubulin deacet-
ylase, acts to block the entry to chromosome condensation in response to mitotic
stress. Oncogene 26, 945–957.
[35] Murone M and Simanis V (1996). The fission yeast dma1 gene is a component
of the spindle assembly checkpoint, required to prevent septum formation and
premature exit from mitosis if spindle function is compromised. EMBO J 15,
6605–6616.
[36] Guertin DA, Venkatram S, Gould KL, and McCollum D (2002). Dma1 pre-
vents mitotic exit and cytokinesis by inhibiting the septation initiation network
(SIN). Dev Cell 3, 779–790.
[37] Michael S, Trave G, Ramu C, Chica C, and Gibson TJ (2008). Discovery of
candidate KEN-box motifs using cell cycle keyword enrichment combined with
native disorder prediction and motif conservation. Bioinformatics 24, 453–457.
[38] Perez de Castro I, de Carcer G, and Malumbres M (2007). A census of mitotic
cancer genes: new insights into tumor cell biology and cancer therapy. Carcino-
genesis 28, 899–912.
[39] Fukuda T, Kondo Y, and Nakagama H (2008). The anti-proliferative effects of
the CHFR depend on the forkhead associated domain, but not E3 ligase activity
mediated by ring finger domain. PLoS ONE 3, e1776.
[40] Privette LM and Petty EM (in press). CHFR: a novel mitotic checkpoint protein
and regulator of tumorigenesis. Transl Oncol.
652 Loss of CHFR Leads to Genomic Instability Privette et al. Neoplasia Vol. 10, No. 7, 2008
